Transplantation of bone marrow and peripheral stem cells

Acta Oncologica

Volumn 35, Issue SUPPL. 7, 1996, Pages 137-140

  Alvegård, Thor ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; WHOLE-BODY IRRADIATION;

EID: 0030320584     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841869609101674     Document Type: Article

References (59)

1. Clift R, Buckner C, Appelbaum F, et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: A randomized trial. Blood 1990; 76: 1867-71. (Cl/48)
2. Plowman P, A review of total body irradiation. Br J Radiol 1988; 22 (Suppl I): 135-44. (L1)
3. Thomas D. Total body irradiation regimens for marrow grafting. Int J Radiat Oncol Biol Phys 1990; 19: 1285-8. (L1)
4. Shank B, O'Reilly R, Cunningham I, et al. Total body irradiation for bone marrow transplantation: The Memorial Sloan-Kettering Cancer Center experience. Radiother Oncol 1990; (Suppl 1): 68-81. (R2/600)
5. Cosset J, Baume D, Pic0 J, et al. Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: A non-randomized comparative study of 54 patients at the Institut Gustave-Roussy. Radiother Oncol 1989: 15: 151-60. (C2/54) (Pubitemid 19169530)
6. Regnier R, Piron A, Debusscher L, van Houtte P, Total body irradiation: Clinical experience at the institute Jules Bordet. Radiother Oncol 1990; (Suppl 1): 128-31. (R2/58)
7. Fyles G, Messner H, Lockwood G, et al. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate. Bone Marrow Transplant 1991; 8: 453-63. (R1/166)
8. Carella A, Frassoni F. van Lint M, et al. Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: An update of the Genoa experience with 159 patients. Ann Hematol 1992; 64: 128-31. (R 1 / 159)
9. Thwaites D, Ritchie G, Parker A. Total body irradiation for bone marrow transplantation in Edinburgh: Techniques, dosimetry and results. Radiother Oncol 1990; (Suppl 1) : 143-5. (R2/32)
10. Champlin R. Preparative regimens for autologous bone marrow transplantation. Blood 1993; 81: 277-80. (O1) (Pubitemid 23027140)
11. Qasim M. Blood and bone marrow response following total body irradiation in patients with lymphosarcomas. Eur J Cancer 1987; 13: 483-7. (O2)
12. Appelbaum F. Sullivan K, Buckner D, et al. Treatment of malignant lymphoma in I00 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol 1987; 5: 1340-7. (R1/100) (Pubitemid 18049871)
13. Gulati S, Yahalom J, Acaba L, et al. Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation. J Clin Oncol 1992; 10: 936-41. (R1/44)
14. Lybeert M. Meerwaldt J, Deneve W, Long term results of low dose total body irradiation for advanced non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 1987; 13: 1167-72. (R 1/68)
15. Petersen F, Appelbaum F, Bigelow C, et al. High-dose cytosine arabinoside. total body irradiation and marrow transplantation for advanced malignant lymphoma. Bone Marrow Transplant 1989; 4: 483-8. (R2/24) (Pubitemid 19236578)
16. Armitage J, Gingrich R, Klassen L. Bierman P, Kumar P. Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma. Cancer Treat Rep 1986; 70: 871 5. (R2/21) (Pubitemid 16065940)
17. Petersen F, Appelbaum R, Hill R. Autologous marrow transplantation for malignant lymphoma: A report of 101 cases from Seattle. J Clin Oncol 1990; 8: 638-47. (RI/101) (Pubitemid 20127247)
18. Appelbaum F, Sullivan K, Buckner C, Treatment of malignant lymphoma in 100 patients with chemotherapy. Total body irradiation and marrow transplantation. J Clin Oncol 1987; 5: 1340-7. (R1/100) (Pubitemid 18049871)
19. Philip R. Armitage J, Spitzer G, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493-8. (R1/100) (Pubitemid 17076232)
20. Gulati S, Shank B. Black P, et al. Autologous bone marrow transplantation for patients with poor prognosis lymphoma. J Clin Oncol 1988: 1303-13. (R1/31)
21. Gandola L, Lombardi F, Siena S, et al. Total body irradiation and high-dose melphalan with bone marrow transplantation at Instituto Nazionale Tumori, Milan, Italy. Radiother Oncol 1990; (Suppl I ) : 105-9. (R2/39)
22. Ghalie R. Richman C, Adler S, et al. Involved field radiation. fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas. Bone Marrow Transplant 1991; 8: 41-5. (R2/123)
23. Rostom A. A review of the place of radiotherapy in myeloma with emphasis on whole body irradiation. Hematol Oncol 1988; 6: 193-8. (O1)
24. Marcus R, Graham-Pole J, Springfield D, et al. High-risk Ewing's sarcoma: End-intensification using autologous bone marrow transplantation. Int J Radiat Oncol Biol Phys 1988: 15: 53-9. (R1/34)
25. Champlin R, Horowitz M, van Bekkum W, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 1989; 73: 606-13. (Ll) (Pubitemid 19060551)
26. Gratwohl A, Hermans J, Goldman J, Gahrton G. Bone marrow transplantation in Europe: Major geographical differences. J Int Med 1993; 233: 333-41. (L1) (Pubitemid 23114982)
27. Leer J, Broerse J, DeVroome H, Chin A. Noordijk E. Dutreix A. Techniques applied for total body irradiation. Radiother Oncol 1990; 18 (Suppl I ) : 10-5. (L1)
28. Quast U. Total body irradiation-review of treatment techniques in Europe. Radiother Oncol 1987; 9: 91 -106. (L1) (Pubitemid 17100662)
29. Svahn-Tapper G, Nilsson P, Jonsson C, Alvegird T. Calculation and measurements of absorbed dose in total body irradiation. Acta Oncol 1990; 29: 627-33. (Ll) (Pubitemid 20294741)
30. Shank B. Techniques of magna-field irradiation. Int J Radiat Oncol Biol Phys 1983; 9: 1925-31. (L1) (Pubitemid 14178676)
31. Van Dyk J, Calvin J, Glasgow G, Podgorsak E. The physical aspects of total and half body irradiation. Report of task Group 29. AAPM report no 17. New York: American Institute of Physics, 1986. (L2)
32. Briot E, Dutreix A. Bridier A. Dosimetry for total body irradiation. Radiother Oncol 1990; 18 (Suppl I ) : 16 29. (L1)
33. Van Dyk J, Dosimetry for total body irradiation. Radiother Oncol 1987; 9: 107-18. ( Ll) (Pubitemid 17100663)
34. Deeg H. Sullivan K. Buckner C, et al. Marrow transplantation for acute non-lymphoblastic leukemia in first remission: Toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1986; l : 151-7. (C1/53)
35. Socie G, Devergie A. Girinski T, et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. Int J Radiat Oncol Biol Phys 1991 ; 20: 397-404. (R1/180)
36. Storb R. Pathogenesis and recent therapeutic approaches to graft-versus-host disease. J Pediatr 1991; 188: 810-3. (L1)
37. Mitsuyasu R, Champlin R. Gale R, et al. Treatment of donor bone marrow with monoclonal anti-T cell antibody and complement for the prevention of graft-versus-host disease: A prospective, randomized double-blind trial. Ann Intern Med 1986; 105: 20-6. (C40/2) (Pubitemid 16097916)
38. Gale R, Butturin A. Bortin M. What does total body irradiation do in marrow transplants for leukemia? Int J Radiat Oncol Biol Phys 1991; 20: 631 4. (L1)
39. Cosset J, Girinsky T. Malaise E. Chaillet M. Dutreix J. Clinical basis for TBI fractionation. Radiother Oncol 1990; 18 (Suppl I ) : 60-7. (L1)
40. Champlin R. Gale R. Bone marrow transplantation for acute leukemia: Recent advances and comparison with alternative therapy. Semin Hematol 1987; 24: 55 67. (L1)
41. Prentice H, Hermans J, Zwaan R. Relapse risk in allogeneic BMT with T-cell depletion of bone marrow. Bone Marrow Transplant 1988; 3: 30 2. (L2)
42. Champlin R, Ho W, Mitsuyasu R. et al. Graft failure and leukemia relapse lollowing T lymphocyte depleted bone marrow transplantation: Effect of intensification of immunosuppressive conditioning. Transplant Proc 1987; 19: 2616-9. (L2)
43. Patterson J, Prentice H. Brenner M, et al. Graft rejection following HLA matched T-lymphocytes depleted bone marrow transplantation. Br J Haematol 1986; 63: 221 -30. (O1) (Pubitemid 16085854)
44. Ringdkn O, Båryd I. Johansson B, et al. Increased mortality by septicemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose rate of total irradiation. Acta Radiol Oncol 1983; 22: 423-8. (R1/34) (Pubitemid 14123813)
45. Deeg H. Storb R. Weiden P, et al. High-dose total-body irradiation and autologous marrow reconstitution in dogs: Dose-rate-related acute toxicity and fractionation-dependent long-term survival. Radiat Res 1981; 88: 385-91. (L1) (Pubitemid 12234013)
46. Keane T, Van Dyk J, Rider W, Idiopathic interstitial pneumonia following bone marrow transplantation: The relationship with total body irradiation. Int J Radiat Oncol Biol Phys 1981; 7: 365-70. (L1)
47. Barrett A, Depledge M. Powles R. Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys 1983: 9:1029-33. (L1) (Pubitemid 13026519)
48. Weiner R, Bortin M. Gale R. et al. Interstitial pneumonitis after bone marrou transplantation. Ann Intern Med 1986: 104: 168-75. (L1) (Pubitemid 16134699)
49. Gulati S, Yahalom J, Whitmarsh K, Clarkson B. Gee T. Factors affecting the outcome of autologous bone marrow transplantation. Ann Oncol 1991: 2 (Suppl I ) : 51-5. (L1)
50. Gulati S, Yahalom J, Portlock C, Autologous bone marrow transplantation. Curr Probl Cancer 1991: 15: 1 57, (L2)
51. Krowda M, Rosenow E. Hodgland H. Pulmonary complications in bone marrow transplantation. Chest 1986: 87: 237 46. (L2)
52. Storb R. Pathogenesis and recent therapeutic approaches to graft-versus-host disease. J Pediatr 1991; 118: 510-3. (L1)
53. Deeg H, Fluornoy N, Sullivan K, et al. Cataracts after total body irradiation and marrow transplantation: A sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 1984; 10: 957-64. (L1) (Pubitemid 14096078)
54. Michel G, Gluckman E, Blaise D, et al. Improvements in outcome for children receiving bone marrow transplantation in first remission of myeloid leukemia: A report from the Groupe d'Etude des Greffes de Moelle Osseuse. J Clin Oncol 1992; 10: 1865.
55. Kader HA, Khanna S, Hutchinson RM, Aukett RJ, Archer J. Pulmonary complications of bone marrow. The impact of variations in total body irradiation parameters. Clin Oncol (R Coll Radiol) 1994; 6: 96.
56. Gentet JC, Bernard JL, Aimard L, Alfonsi SM, Raybaud C. Veno-occlusive disease in children after intensive chemo- and radiotherapy and repeated halothane anesthesias. A report of 2 cases. Acta Oncol 1988; 27: 579.
57. Bozzola M, Giorgiani G, Locatelli F, et al. Growth of children after bone marrow transplantation. Horm Res 1993; 39: 122.
58. Blaise D, Maraninchi D. Archimbaud E, et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: A report from the Groupe d'Etudes de la Greffe de Mode Osseuse. Blood 1992; 79: 2578-82. (C1/101)
59. Morgan M, Dodds A. Atkinson K, Szer J, Downs K, Biggs J. The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation. Br J Haematol 1991; 77: 5292-34. (R1/233)